Search Results - "Pavitt, Darrell V."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Lipoprotein separation in a novel iodixanol density gradient, for composition, density, and phenotype analysis by Yee, Michael S., Pavitt, Darrell V., Tan, Tira, Venkatesan, Soundararajan, Godsland, Ian F., Richmond, William, Johnston, Desmond G.

    Published in Journal of lipid research (01-06-2008)
    “…Separation of lipoproteins by traditional sequential salt density floatation is a prolonged process (∼72 h) with variable recovery, whereas iodixanol-based,…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Relationship of renal function to homocysteine and lipoprotein(a) levels: The frequency of the combination of both risk factors in chronic renal impairment by Parsons, Darren S., Reaveley, David A., Pavitt, Darrell V., Brown, Edwina A.

    Published in American journal of kidney diseases (01-11-2002)
    “…Background: Total homocysteine (tHcy) and lipoprotein(a) [Lp(a)] levels have been recognized as risk factors for vascular disease. The combination of elevated…”
    Get full text
    Journal Article
  4. 4

    Assay of serum allantoin in humans by gas chromatography–mass spectrometry by Pavitt, Darrell V, de Fonseka, Sue, Al-Khalaf, Nisrin, Cam, Janice M, Reaveley, David A

    Published in Clinica chimica acta (01-04-2002)
    “…Background: The small amount of allantoin present in human serum results from free radical (FR) action on urate and may provide a stable marker of free radical…”
    Get full text
    Journal Article
  5. 5

    Intrahepatic Insulin Exposure, Intrahepatocellular Lipid and Regional Body Fat in Nonalcoholic Fatty Liver Disease by Mehta, Sanjeev R, Godsland, Ian F, Thomas, E. Louise, Pavitt, Darrell V, Morin, Stanislas X, Bell, Jimmy D, Taylor-Robinson, Simon D, Johnston, Desmond G

    “…Context: Insulin is pivotal in regulating hepatic lipid synthesis, metabolism, and export. Objective: We tested the hypothesis that intrahepatic insulin…”
    Get full text
    Journal Article
  6. 6

    Changes in lipoprotein profile and urinary albumin excretion in familial LCAT deficiency with lipid lowering therapy by Yee, Michael S, Pavitt, Darrell V, Richmond, William, Cook, H. Terence, McLean, Adam G, Valabhji, Jonathan, Elkeles, Robert S

    Published in Atherosclerosis (01-08-2009)
    “…Abstract Familial lecithin:cholesterol acyltransferase deficiency (FLD) is a monogenic autosomal recessive condition, affecting cholesterol esterification and…”
    Get full text
    Journal Article
  7. 7

    Lipoprotein (a) levels in those with high molecular weight apo (a) isoforms may remain low in a significant proportion of patients with end-stage renal disease by Parsons, Darren S., Reaveley, David A., Pavitt, Darrell V., Misra, Madhukar, Brown, Edwina A.

    Published in Nephrology, dialysis, transplantation (01-09-2003)
    “…Background. Studies have reported an increase in median Lipoprotein (Lp) (a) in patients with high molecular weight (HMW) apolipoprotein (apo) (a) isoforms and…”
    Get full text
    Journal Article
  8. 8

    Effects of the peptide release inhibitor, octreotide, on daytime hypotension and on nocturnal hypertension in primary autonomic failure by Alam, M, Smith, G, Bleasdale-Barr, K, Pavitt, D V, Mathias, C J

    Published in Journal of hypertension (01-12-1995)
    “…To investigate the effects of the somatostatin analogue octreotide, which inhibits the release of various peptides, on 24-h ambulatory blood pressure profiles…”
    Get more information
    Journal Article
  9. 9